1. Home
  2. CIG vs GPCR Comparison

CIG vs GPCR Comparison

Compare CIG & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comp En De Mn Cemig ADS

CIG

Comp En De Mn Cemig ADS

HOLD

Current Price

$2.16

Market Cap

5.8B

Sector

Utilities

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$82.04

Market Cap

6.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIG
GPCR
Founded
1952
2016
Country
Brazil
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.3B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
CIG
GPCR
Price
$2.16
$82.04
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$103.09
AVG Volume (30 Days)
4.5M
1.2M
Earning Date
03-20-2026
02-26-2026
Dividend Yield
11.67%
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$7,960,960,695.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.44
N/A
Revenue Growth
9.92
N/A
52 Week Low
$1.59
$13.22
52 Week High
$2.30
$94.90

Technical Indicators

Market Signals
Indicator
CIG
GPCR
Relative Strength Index (RSI) 56.27 54.31
Support Level $1.96 $86.10
Resistance Level $2.25 $92.06
Average True Range (ATR) 0.06 4.80
MACD 0.01 -1.62
Stochastic Oscillator 69.20 19.77

Price Performance

Historical Comparison
CIG
GPCR

About CIG Comp En De Mn Cemig ADS

Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: